🇺🇸 FDA
Patent

US 6979451

Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use

expired A61KA61K39/00A61K39/0233

Quick answer

US patent 6979451 (Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use) held by The Board of Regents for Oklahoma State University expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents for Oklahoma State University
Grant date
Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K39/00, A61K39/0233